rethinkTHC Search
Menu
Study breakdown

Synthetic Cannabinoids Make Fentanyl Overdoses Harder to Reverse with Naloxone

Animal StudyModerate evidence
The takeaway

When synthetic cannabinoids were combined with fentanyl in mice, respiratory depression worsened and naloxone became less effective at reversing the overdose.

Emergency medicine providers, harm reduction workers, and overdose reversal researchers.

Synthetic cannabinoid + fentanyl combinations resisted naloxone rescue that worked for fentanyl alone

What the researchers found

Co-administration of fentanyl with synthetic cannabinoids (JWH-018 or 5F-ADB-PINACA) exacerbated respiratory depression beyond either drug alone. Critically, these combinations conferred resistance to naloxone rescue. Neither naloxone nor the CB1 antagonist rimonabant alone fully reversed the combined respiratory depression. The interaction appeared to involve both pharmacodynamic (receptor-level) and pharmacokinetic (blood-level) mechanisms.

Why it matters

Synthetic cannabinoids are frequently found as adulterants in street opioids, and fentanyl is found in synthetic cannabinoid products. This study provides a biological explanation for the growing phenomenon of naloxone-resistant overdoses.

The numbers in context

Two SCRAs tested: JWH-018 (naphthyl indole) and 5F-ADB-PINACA (indazole carboxamide). Tolerance developed to JWH-018 but not 5F-ADB-PINACA respiratory effects. Naloxone rescued fentanyl-only respiratory depression but not SCRA-fentanyl combinations.

How the study worked

Whole body plethysmography in mice measuring respiratory rate after acute and chronic administration of fentanyl, two structurally distinct synthetic cannabinoids, and their combinations. Antagonist rescue studies with naloxone, rimonabant, and both combined. Blood sampling at peak respiratory depression for pharmacokinetic analysis.

What this study cannot tell us

Mouse model may not perfectly predict human overdose pharmacology. Specific SCRA-fentanyl ratios used may not reflect street drug compositions. Only two SCRAs tested among hundreds of circulating compounds. Pharmacokinetic interactions were suggested but not fully characterized.

How to read the evidence

Well-designed animal study with clear mechanistic findings, but translation to human overdose scenarios requires clinical confirmation.

When this study was published

2025 publication.

The bigger picture

The finding that synthetic cannabinoid contamination can render naloxone less effective has immediate implications for overdose response protocols. First responders may need to carry CB1 antagonists alongside naloxone in areas where SCRA-contaminated opioids are prevalent.

Questions still open

  • Should CB1 antagonists be added to overdose reversal kits in areas with SCRA-contaminated opioids?
  • Do other SCRAs produce the same naloxone resistance when combined with fentanyl?

Read the original research

Synthetic cannabinoid receptor agonists exacerbate fentanyl-elicited respiratory depression and confer resistance to naloxone rescue in mice.

Drug and alcohol dependence, 272, 112672

Citation

James, Jared C; Thrush, Jessica R; Yusufali, Taher M; Shaw, Hannah E; Avram, Marina; Moran, Jeffery H; Fantegrossi, William E. (2025). Synthetic cannabinoid receptor agonists exacerbate fentanyl-elicited respiratory depression and confer resistance to naloxone rescue in mice.. Drug and alcohol dependence, 272, 112672. https://doi.org/10.1016/j.drugalcdep.2025.112672

Explore the wider topic